Secchi M B, Mancarella S, Wu S C, Bettazzi L, Pietra M, Loche G, Merlo E M
Divisione di Medicina Interna, Ospedale Bassini, Cinisello Balsamo, Milano.
Ann Ital Med Int. 1993 Jul-Sep;8(3):175-8.
In order to verify the utility of the captopril test (CT) in diagnosing renal artery stenosis we performed a prospective study in 94 consecutive patients (40 females, 54 males, mean age 52.4 +/- 12.3 years) suspected of having renovascular hypertension and with a serum level of creatinine < 2 mg/dl. Antihypertensive drugs were withdrawn one week before the CT or, if this was considered unsafe, patients were treated with nifedipine or diltiazem (53 subjects; 56.4%). We used renal angiography and the Muller criteria to interpret the CT. Our results were as follows: sensitivity, 92%; specificity, 96%; positive predictive value, 88%; and negative predictive value, 97%. In our study a simplified criterion for positive CT-postcaptopril plasma renin activity > 10 ng/mL/h-provided a similar diagnostic value. We conclude that the captopril test is a useful screening test for the detection of renal artery stenosis in selected hypertensive patients and that it can also be reliably performed in patients who are taking calcium antagonists.
为了验证卡托普利试验(CT)在诊断肾动脉狭窄中的效用,我们对94例连续患者(40例女性,54例男性,平均年龄52.4±12.3岁)进行了一项前瞻性研究,这些患者疑似患有肾血管性高血压且血清肌酐水平<2mg/dl。在CT检查前一周停用降压药,或者,如果认为这样不安全,则用硝苯地平或地尔硫卓治疗患者(53例受试者;56.4%)。我们使用肾血管造影和米勒标准来解释CT结果。我们的结果如下:敏感性为92%;特异性为96%;阳性预测值为88%;阴性预测值为97%。在我们的研究中,一个简化的CT阳性标准——卡托普利后血浆肾素活性>10ng/mL/h——提供了相似的诊断价值。我们得出结论,卡托普利试验是一种用于在选定的高血压患者中检测肾动脉狭窄的有用筛查试验,并且在服用钙拮抗剂的患者中也能可靠地进行。